NYSE:CVS 29 October 2025 - 25 December 2025

CVS Health Corporation ended the Christmas Eve session higher, then eased modestly after hours as trading thinned into the holiday. CVS closed at $79.12, up 1.38%, in a shortened session that ended at 1:00 p.m. Eastern. In after-hours trading, the stock was $79.01 at 5:00 p.m. Eastern, down about 0.14% from the close. StockAnalysis

CVS Health Corporation has turned into one of 2025’s surprise winners in the healthcare sector. After a bruising 2023–2024 period of cost pressures and integration headaches, CVS stock has climbed roughly 70–80% year‑to‑date in 2025, making it one of the top performers in the S&P 500’s health-care names. Reuters+1 As of the latest close, CVS shares trade around $80.6 with a daily gain of about 2%, giving the company a market value just under $100 billion. Trefis

In Wednesday’s earnings announcement, CVS Health beat expectations across the board. The pharmacy-and-insurance giant reported Q3 total sales of $102.9 billion and adjusted profit of $1.60 per share cvshealth.com gurufocus.com, handily exceeding consensus. Revenue was about $7.5 billion higher than a year ago, driven by volume gains and modest price increases. The results “exceeded Wall Street’s expectations,” according to the Associated Press timesunion.com. Management simultaneously hiked its full-year guidance: adjusted earnings are now seen at $6.55–$6.65 per share cvshealth.com timesunion.com. This marks CVS’s third profit outlook raise in 2025, reflecting confidence in its turnaround plan. Investors rewarded the news – CVS stock spiked after the close – adding to a strong rally this year investing.com.